Profile avatar
josephsassinemd.bsky.social
Transplant ID Faculty & ID Fellowship APD at University of Oklahoma | #TxID | Cancer ID | #ChemalyTeam | Views my own | RT ≠ endorsement | 🇫🇷🇱🇧
18 posts 325 followers 227 following
Regular Contributor
Posts 13 Comments 9

Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care. Tracks come with option for 12-credit certificates, covered by the program: medicine.ouhsc.edu/academic-dep... 🧵 #IDSky #TxID

submitted 15 days ago • 1 comment

How to prevent infections in the increasingly immunocompromised traveler? Part 1 (non-transplant) is out now! Stay tuned for part 2! @ritawilson.bsky.social @andhen25.bsky.social @ou.edu #IDSky #TxID journals.sagepub.com/doi/10.1177/...

submitted 34 days ago • 0 comments

Out now, everything you need to know, that is known and not known, about herpesviruses after CAR T and BsAb, in our review with Dr Emily Siegrist and Dr Roy Chemaly! @mdanderson.bsky.social @ou.edu #IDSky #TxID www.mdpi.com/1999-4915/17...

submitted 39 days ago • 0 comments

Spoke to @koconews.bsky.social about norovirus, clinical presentation and preventive measures #IDSky www.koco.com/article/okla...

submitted 44 days ago • 0 comments

T-SPOT.TB performs much better in many immunocompromised populations IMO, but historically was logistically more difficult from CA due to time-sensitive FedEx of samples to Memphis which failed a lot with winter storms. Less an issue now that Quest bought T-SPOT.

submitted 59 days ago • 0 comments

T-SPOT resulted in - fewer indeterminate results (than QFT) - more “actionable” results (than QFT) in certain immunocompromised populations #TBSky

submitted 60 days ago • 0 comments

Out now in @thetxidjournal.bsky.social! T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB. #TxID #IDSky onlinelibrary.wiley.com/doi/10.1111/...

submitted 60 days ago • 1 comment

A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC: https://doi.org/10.1093/jacamr/dlae144 #JACAMRNews @bryanpwhite.bsky.social

submitted 61 days ago • 0 comments

Special theme issue in @cmijournal.bsky.social - Infections in immunocompromised hosts, edited by Dr Roy Chemaly, with a series of high yield #TxID reviews, including our review of herpesviruses after allogeneic HCT #IDSky www.clinicalmicrobiologyandinfection.com/article/S119...

submitted 70 days ago • 2 comments

How to manage spinal implant infections? Read all about it. #IDSky By yours truly. academic.oup.com/cid/article/...

submitted 71 days ago • 7 comments

Recently spoke with Health IT News about the results of our innovative trial of remote therapeutic monitoring in OPAT, how RTM helped us reduce infection-related readmissions and improve patient adherence to IV ABx #IDSky #OPAT @ou.edu www.healthcareitnews.com/news/remote-...

submitted 74 days ago • 1 comment

Check out our most recent work - A large database analysis of viral and fungal infections after CAR T cell therapy, published at @cmijournal.bsky.social, with @andhen25.bsky.social #IDSky #TxID www.clinicalmicrobiologyandinfection.com/article/S119...

submitted 74 days ago • 0 comments

First post on #IDSky We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025. Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with! DM me for details! medicine.ouhsc.edu/academic-dep...

submitted 74 days ago • 0 comments